APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antibiotic API

Compare research editions
View pricing & licenses

Selected research

Industry Research

Antibiotic API Industry Research Report 2026

28 December 2025148 pages

Choose your research edition.

Industry ResearchAntibiotic API Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibiotic API Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Antibiotic API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibiotic API Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Antibiotic API Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Antibiotic API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Antibiotic API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Antibiotic API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Antibiotic API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Antibiotic API include UNITED LABORATORIES, HUAFANG PHARMACEUTICAL, Dongying Pharmaceutical, SALUBRIS, Shyndec Pharmaceutical, Dawnrays Pharmaceutical, CSPC, RUIYING PIONEER PHARMACEUTICAL and REYOUNG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Antibiotic API market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Antibiotic API Market by Company

UNITED LABORATORIES

HUAFANG PHARMACEUTICAL

Dongying Pharmaceutical

SALUBRIS

Shyndec Pharmaceutical

Dawnrays Pharmaceutical

CSPC

RUIYING PIONEER PHARMACEUTICAL

REYOUNG

QILU ANTIBIOTICS PHARMACEUTICAL

Novartis

LUKANG PHARMACEUTICAL

Medya Pharmaceutical

KELUN

North China Pharmaceutical

Harbin Pharmaceutical Group

FUKANG PHARMACEUTICAL

FUAN PHARMACEUTICAL

Orchid Pharma

Nectar Lifesciences

Centrient Pharmaceuticals

Aurobindo Pharma

ACS Dobfar

Antibiotic API Segment by Type

Aminoglycosides

Macrolides

Quinolones

Lincomycins

Penicillins

Tetracyclines

Cephalosporins

Others

Antibiotic API Segment by Application

Oral Medicine

Injection Medicine

Antibiotic API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibiotic API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibiotic API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibiotic API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Antibiotic API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Antibiotic API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Antibiotic API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antibiotic API Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Antibiotic API Sales (Tons) of Manufacturers (2021-2026) Table 7. Global Antibiotic API Sales Market Share by Manufacturers (2021-2026) Table 8. Global Antibiotic API Revenue of Manufacturers (2021-2026) Table 9. Global Antibiotic API Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Antibiotic API Average Price (US$/Kg) of Manufacturers (2021-2026) Table 11. Global Antibiotic API Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Antibiotic API, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Antibiotic API, Product Type & Application Table 14. Global Antibiotic API Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Antibiotic API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. UNITED LABORATORIES Company Information Table 19. UNITED LABORATORIES Business Overview Table 20. UNITED LABORATORIES Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 21. UNITED LABORATORIES Antibiotic API Product Portfolio Table 22. UNITED LABORATORIES Recent Developments Table 23. HUAFANG PHARMACEUTICAL Company Information Table 24. HUAFANG PHARMACEUTICAL Business Overview Table 25. HUAFANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 26. HUAFANG PHARMACEUTICAL Antibiotic API Product Portfolio Table 27. HUAFANG PHARMACEUTICAL Recent Developments Table 28. Dongying Pharmaceutical Company Information Table 29. Dongying Pharmaceutical Business Overview Table 30. Dongying Pharmaceutical Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 31. Dongying Pharmaceutical Antibiotic API Product Portfolio Table 32. Dongying Pharmaceutical Recent Developments Table 33. SALUBRIS Company Information Table 34. SALUBRIS Business Overview Table 35. SALUBRIS Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 36. SALUBRIS Antibiotic API Product Portfolio Table 37. SALUBRIS Recent Developments Table 38. Shyndec Pharmaceutical Company Information Table 39. Shyndec Pharmaceutical Business Overview Table 40. Shyndec Pharmaceutical Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 41. Shyndec Pharmaceutical Antibiotic API Product Portfolio Table 42. Shyndec Pharmaceutical Recent Developments Table 43. Dawnrays Pharmaceutical Company Information Table 44. Dawnrays Pharmaceutical Business Overview Table 45. Dawnrays Pharmaceutical Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 46. Dawnrays Pharmaceutical Antibiotic API Product Portfolio Table 47. Dawnrays Pharmaceutical Recent Developments Table 48. CSPC Company Information Table 49. CSPC Business Overview Table 50. CSPC Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 51. CSPC Antibiotic API Product Portfolio Table 52. CSPC Recent Developments Table 53. RUIYING PIONEER PHARMACEUTICAL Company Information Table 54. RUIYING PIONEER PHARMACEUTICAL Business Overview Table 55. RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 56. RUIYING PIONEER PHARMACEUTICAL Antibiotic API Product Portfolio Table 57. RUIYING PIONEER PHARMACEUTICAL Recent Developments Table 58. REYOUNG Company Information Table 59. REYOUNG Business Overview Table 60. REYOUNG Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 61. REYOUNG Antibiotic API Product Portfolio Table 62. REYOUNG Recent Developments Table 63. QILU ANTIBIOTICS PHARMACEUTICAL Company Information Table 64. QILU ANTIBIOTICS PHARMACEUTICAL Business Overview Table 65. QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Product Portfolio Table 67. QILU ANTIBIOTICS PHARMACEUTICAL Recent Developments Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Novartis Antibiotic API Product Portfolio Table 72. Novartis Recent Developments Table 73. LUKANG PHARMACEUTICAL Company Information Table 74. LUKANG PHARMACEUTICAL Business Overview Table 75. LUKANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. LUKANG PHARMACEUTICAL Antibiotic API Product Portfolio Table 77. LUKANG PHARMACEUTICAL Recent Developments Table 78. Medya Pharmaceutical Company Information Table 79. Medya Pharmaceutical Business Overview Table 80. Medya Pharmaceutical Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Medya Pharmaceutical Antibiotic API Product Portfolio Table 82. Medya Pharmaceutical Recent Developments Table 83. KELUN Company Information Table 84. KELUN Business Overview Table 85. KELUN Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. KELUN Antibiotic API Product Portfolio Table 87. KELUN Recent Developments Table 88. North China Pharmaceutical Company Information Table 89. North China Pharmaceutical Business Overview Table 90. North China Pharmaceutical Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. North China Pharmaceutical Antibiotic API Product Portfolio Table 92. North China Pharmaceutical Recent Developments Table 93. Harbin Pharmaceutical Group Company Information Table 94. Harbin Pharmaceutical Group Business Overview Table 95. Harbin Pharmaceutical Group Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. Harbin Pharmaceutical Group Antibiotic API Product Portfolio Table 97. Harbin Pharmaceutical Group Recent Developments Table 98. FUKANG PHARMACEUTICAL Company Information Table 99. FUKANG PHARMACEUTICAL Business Overview Table 100. FUKANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. FUKANG PHARMACEUTICAL Antibiotic API Product Portfolio Table 102. FUKANG PHARMACEUTICAL Recent Developments Table 103. FUAN PHARMACEUTICAL Company Information Table 104. FUAN PHARMACEUTICAL Business Overview Table 105. FUAN PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. FUAN PHARMACEUTICAL Antibiotic API Product Portfolio Table 107. FUAN PHARMACEUTICAL Recent Developments Table 108. Orchid Pharma Company Information Table 109. Orchid Pharma Business Overview Table 110. Orchid Pharma Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Orchid Pharma Antibiotic API Product Portfolio Table 112. Orchid Pharma Recent Developments Table 113. Nectar Lifesciences Company Information Table 114. Nectar Lifesciences Business Overview Table 115. Nectar Lifesciences Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 116. Nectar Lifesciences Antibiotic API Product Portfolio Table 117. Nectar Lifesciences Recent Developments Table 118. Centrient Pharmaceuticals Company Information Table 119. Centrient Pharmaceuticals Business Overview Table 120. Centrient Pharmaceuticals Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 121. Centrient Pharmaceuticals Antibiotic API Product Portfolio Table 122. Centrient Pharmaceuticals Recent Developments Table 123. Aurobindo Pharma Company Information Table 124. Aurobindo Pharma Business Overview Table 125. Aurobindo Pharma Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 126. Aurobindo Pharma Antibiotic API Product Portfolio Table 127. Aurobindo Pharma Recent Developments Table 128. ACS Dobfar Company Information Table 129. ACS Dobfar Business Overview Table 130. ACS Dobfar Antibiotic API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 131. ACS Dobfar Antibiotic API Product Portfolio Table 132. ACS Dobfar Recent Developments Table 133. Global Antibiotic API Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 134. Global Antibiotic API Sales by Region (2021-2026) & (Tons) Table 135. Global Antibiotic API Sales Market Share by Region (2021-2026) Table 136. Global Antibiotic API Sales by Region (2027-2032) & (Tons) Table 137. Global Antibiotic API Sales Market Share by Region (2027-2032) Table 138. Global Antibiotic API Revenue by Region (2021-2026) & (US$ Million) Table 139. Global Antibiotic API Revenue Market Share by Region (2021-2026) Table 140. Global Antibiotic API Revenue by Region (2027-2032) & (US$ Million) Table 141. Global Antibiotic API Revenue Market Share by Region (2027-2032) Table 142. North America Antibiotic API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. North America Antibiotic API Sales by Country (2021-2026) & (Tons) Table 144. North America Antibiotic API Sales by Country (2027-2032) & (Tons) Table 145. North America Antibiotic API Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Antibiotic API Revenue by Country (2027-2032) & (US$ Million) Table 147. Europe Antibiotic API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Europe Antibiotic API Sales by Country (2021-2026) & (Tons) Table 149. Europe Antibiotic API Sales by Country (2027-2032) & (Tons) Table 150. Europe Antibiotic API Revenue by Country (2021-2026) & (US$ Million) Table 151. Europe Antibiotic API Revenue by Country (2027-2032) & (US$ Million) Table 152. Asia Pacific Antibiotic API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Asia Pacific Antibiotic API Sales by Country (2021-2026) & (Tons) Table 154. Asia Pacific Antibiotic API Sales by Country (2027-2032) & (Tons) Table 155. Asia Pacific Antibiotic API Revenue by Country (2021-2026) & (US$ Million) Table 156. Asia Pacific Antibiotic API Revenue by Country (2027-2032) & (US$ Million) Table 157. South America Antibiotic API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. South America Antibiotic API Sales by Country (2021-2026) & (Tons) Table 159. South America Antibiotic API Sales by Country (2027-2032) & (Tons) Table 160. South America Antibiotic API Revenue by Country (2021-2026) & (US$ Million) Table 161. South America Antibiotic API Revenue by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Antibiotic API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Middle East and Africa Antibiotic API Sales by Country (2021-2026) & (Tons) Table 164. Middle East and Africa Antibiotic API Sales by Country (2027-2032) & (Tons) Table 165. Middle East and Africa Antibiotic API Revenue by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Antibiotic API Revenue by Country (2027-2032) & (US$ Million) Table 167. Global Antibiotic API Sales by Type (2021-2026) & (Tons) Table 168. Global Antibiotic API Sales by Type (2027-2032) & (Tons) Table 169. Global Antibiotic API Sales Market Share by Type (2021-2026) Table 170. Global Antibiotic API Sales Market Share by Type (2027-2032) Table 171. Global Antibiotic API Revenue by Type (2021-2026) & (US$ Million) Table 172. Global Antibiotic API Revenue by Type (2027-2032) & (US$ Million) Table 173. Global Antibiotic API Revenue Market Share by Type (2021-2026) Table 174. Global Antibiotic API Revenue Market Share by Type (2027-2032) Table 175. Global Antibiotic API Price by Type (2021-2026) & (US$/Kg) Table 176. Global Antibiotic API Price by Type (2027-2032) & (US$/Kg) Table 177. Global Antibiotic API Sales by Application (2021-2026) & (Tons) Table 178. Global Antibiotic API Sales by Application (2027-2032) & (Tons) Table 179. Global Antibiotic API Sales Market Share by Application (2021-2026) Table 180. Global Antibiotic API Sales Market Share by Application (2027-2032) Table 181. Global Antibiotic API Revenue by Application (2021-2026) & (US$ Million) Table 182. Global Antibiotic API Revenue by Application (2027-2032) & (US$ Million) Table 183. Global Antibiotic API Revenue Market Share by Application (2021-2026) Table 184. Global Antibiotic API Revenue Market Share by Application (2027-2032) Table 185. Global Antibiotic API Price by Application (2021-2026) & (US$/Kg) Table 186. Global Antibiotic API Price by Application (2027-2032) & (US$/Kg) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Antibiotic API Distributors List Table 190. Antibiotic API Customers List Table 191. Antibiotic API Industry Trends Table 192. Antibiotic API Industry Drivers Table 193. Antibiotic API Industry Restraints Table 194. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Antibiotic API Product Image Figure 5. Global Antibiotic API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Antibiotic API Market Size (2021-2032) & (US$ Million) Figure 7. Global Antibiotic API Sales (2021-2032) & (Tons) Figure 8. Global Antibiotic API Average Price (US$/Kg) & (2021-2032) Figure 9. Aminoglycosides Product Image Figure 10. Macrolides Product Image Figure 11. Quinolones Product Image Figure 12. Lincomycins Product Image Figure 13. Penicillins Product Image Figure 14. Tetracyclines Product Image Figure 15. Cephalosporins Product Image Figure 16. Others Product Image Figure 17. Oral Medicine Product Image Figure 18. Injection Medicine Product Image Figure 19. Global Antibiotic API Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Antibiotic API, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Antibiotic API Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Antibiotic API Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Antibiotic API Sales by Region in 2025 Figure 25. Global Antibiotic API Revenue by Region in 2025 Figure 26. North America Antibiotic API Market Size by Country in 2025 Figure 27. North America Antibiotic API Sales Market Share by Country (2021-2032) Figure 28. North America Antibiotic API Revenue Market Share by Country (2021-2032) Figure 29. United States Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Antibiotic API Market Size by Country in 2025 Figure 32. Europe Antibiotic API Sales Market Share by Country (2021-2032) Figure 33. Europe Antibiotic API Revenue Market Share by Country (2021-2032) Figure 34. Germany Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Nordic Countries Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Antibiotic API Market Size by Country in 2025 Figure 41. Asia Pacific Antibiotic API Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Antibiotic API Revenue Market Share by Country (2021-2032) Figure 43. China Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. China Taiwan Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Antibiotic API Market Size by Country in 2025 Figure 52. South America Antibiotic API Sales Market Share by Country (2021-2032) Figure 53. South America Antibiotic API Revenue Market Share by Country (2021-2032) Figure 54. Mexico Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Brazil Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Antibiotic API Market Size by Country in 2025 Figure 58. Middle East and Africa Antibiotic API Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Antibiotic API Revenue Market Share by Country (2021-2032) Figure 60. Turkey Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. UAE Antibiotic API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Global Antibiotic API Sales Market Share by Type (2021-2032) Figure 64. Global Antibiotic API Revenue Market Share by Type (2021-2032) Figure 65. Global Antibiotic API Price (US$/Kg) by Type (2021-2032) Figure 66. Global Antibiotic API Sales Market Share by Application (2021-2032) Figure 67. Global Antibiotic API Revenue Market Share by Application (2021-2032) Figure 68. Global Antibiotic API Price (US$/Kg) by Application (2021-2032) Figure 69. Antibiotic API Value Chain Figure 70. Antibiotic API Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Antibiotic API Industry Opportunities and Challenges

Scope & coverage.

Types
  • Aminoglycosides
  • Macrolides
  • Quinolones
  • Lincomycins
  • Penicillins
  • Tetracyclines
  • Cephalosporins
  • Others
Applications
  • Oral Medicine
  • Injection Medicine
Companies covered
  • UNITED LABORATORIES
  • HUAFANG PHARMACEUTICAL
  • Dongying Pharmaceutical
  • SALUBRIS
  • Shyndec Pharmaceutical
  • Dawnrays Pharmaceutical
  • CSPC
  • RUIYING PIONEER PHARMACEUTICAL
  • REYOUNG
  • QILU ANTIBIOTICS PHARMACEUTICAL
  • Novartis
  • LUKANG PHARMACEUTICAL
  • Medya Pharmaceutical
  • KELUN
  • North China Pharmaceutical
  • Harbin Pharmaceutical Group
  • FUKANG PHARMACEUTICAL
  • FUAN PHARMACEUTICAL
  • Orchid Pharma
  • Nectar Lifesciences
  • Centrient Pharmaceuticals
  • Aurobindo Pharma
  • ACS Dobfar

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Antibiotic API Market Size (2021-2032)
  4. 2.2.2 Global Antibiotic API Sales (2021-2032)
  5. 2.2.3 Global Antibiotic API Market Average Price (2021-2032)
  6. 2.3 Antibiotic API by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Aminoglycosides
  9. 2.3.3 Macrolides
  10. 2.3.4 Quinolones
  11. 2.3.5 Lincomycins
  12. 2.3.6 Penicillins
  13. 2.3.7 Tetracyclines
  14. 2.3.8 Cephalosporins
  15. 2.3.9 Others
  16. 2.4 Antibiotic API by Application
  17. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  18. 2.4.2 Oral Medicine
  19. 2.4.3 Injection Medicine
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Antibiotic API Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Antibiotic API Sales (Tons) of Manufacturers (2021-2026)
  3. 3.3 Global Antibiotic API Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Antibiotic API Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Antibiotic API Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Antibiotic API, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Antibiotic API, Product Type & Application
  8. 3.8 Global Manufacturers of Antibiotic API, Established Date
  9. 3.9 Global Antibiotic API Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 UNITED LABORATORIES
  2. 4.1.1 UNITED LABORATORIES Company Information
  3. 4.1.2 UNITED LABORATORIES Business Overview
  4. 4.1.3 UNITED LABORATORIES Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 UNITED LABORATORIES Antibiotic API Product Portfolio
  6. 4.1.5 UNITED LABORATORIES Recent Developments
  7. 4.2 HUAFANG PHARMACEUTICAL
  8. 4.2.1 HUAFANG PHARMACEUTICAL Company Information
  9. 4.2.2 HUAFANG PHARMACEUTICAL Business Overview
  10. 4.2.3 HUAFANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 HUAFANG PHARMACEUTICAL Antibiotic API Product Portfolio
  12. 4.2.5 HUAFANG PHARMACEUTICAL Recent Developments
  13. 4.3 Dongying Pharmaceutical
  14. 4.3.1 Dongying Pharmaceutical Company Information
  15. 4.3.2 Dongying Pharmaceutical Business Overview
  16. 4.3.3 Dongying Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Dongying Pharmaceutical Antibiotic API Product Portfolio
  18. 4.3.5 Dongying Pharmaceutical Recent Developments
  19. 4.4 SALUBRIS
  20. 4.4.1 SALUBRIS Company Information
  21. 4.4.2 SALUBRIS Business Overview
  22. 4.4.3 SALUBRIS Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 SALUBRIS Antibiotic API Product Portfolio
  24. 4.4.5 SALUBRIS Recent Developments
  25. 4.5 Shyndec Pharmaceutical
  26. 4.5.1 Shyndec Pharmaceutical Company Information
  27. 4.5.2 Shyndec Pharmaceutical Business Overview
  28. 4.5.3 Shyndec Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Shyndec Pharmaceutical Antibiotic API Product Portfolio
  30. 4.5.5 Shyndec Pharmaceutical Recent Developments
  31. 4.6 Dawnrays Pharmaceutical
  32. 4.6.1 Dawnrays Pharmaceutical Company Information
  33. 4.6.2 Dawnrays Pharmaceutical Business Overview
  34. 4.6.3 Dawnrays Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Dawnrays Pharmaceutical Antibiotic API Product Portfolio
  36. 4.6.5 Dawnrays Pharmaceutical Recent Developments
  37. 4.7 CSPC
  38. 4.7.1 CSPC Company Information
  39. 4.7.2 CSPC Business Overview
  40. 4.7.3 CSPC Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 CSPC Antibiotic API Product Portfolio
  42. 4.7.5 CSPC Recent Developments
  43. 4.8 RUIYING PIONEER PHARMACEUTICAL
  44. 4.8.1 RUIYING PIONEER PHARMACEUTICAL Company Information
  45. 4.8.2 RUIYING PIONEER PHARMACEUTICAL Business Overview
  46. 4.8.3 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Product Portfolio
  48. 4.8.5 RUIYING PIONEER PHARMACEUTICAL Recent Developments
  49. 4.9 REYOUNG
  50. 4.9.1 REYOUNG Company Information
  51. 4.9.2 REYOUNG Business Overview
  52. 4.9.3 REYOUNG Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 REYOUNG Antibiotic API Product Portfolio
  54. 4.9.5 REYOUNG Recent Developments
  55. 4.10 QILU ANTIBIOTICS PHARMACEUTICAL
  56. 4.10.1 QILU ANTIBIOTICS PHARMACEUTICAL Company Information
  57. 4.10.2 QILU ANTIBIOTICS PHARMACEUTICAL Business Overview
  58. 4.10.3 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Product Portfolio
  60. 4.10.5 QILU ANTIBIOTICS PHARMACEUTICAL Recent Developments
  61. 4.11 Novartis
  62. 4.11.1 Novartis Company Information
  63. 4.11.2 Novartis Business Overview
  64. 4.11.3 Novartis Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Novartis Antibiotic API Product Portfolio
  66. 4.11.5 Novartis Recent Developments
  67. 4.12 LUKANG PHARMACEUTICAL
  68. 4.12.1 LUKANG PHARMACEUTICAL Company Information
  69. 4.12.2 LUKANG PHARMACEUTICAL Business Overview
  70. 4.12.3 LUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 LUKANG PHARMACEUTICAL Antibiotic API Product Portfolio
  72. 4.12.5 LUKANG PHARMACEUTICAL Recent Developments
  73. 4.13 Medya Pharmaceutical
  74. 4.13.1 Medya Pharmaceutical Company Information
  75. 4.13.2 Medya Pharmaceutical Business Overview
  76. 4.13.3 Medya Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Medya Pharmaceutical Antibiotic API Product Portfolio
  78. 4.13.5 Medya Pharmaceutical Recent Developments
  79. 4.14 KELUN
  80. 4.14.1 KELUN Company Information
  81. 4.14.2 KELUN Business Overview
  82. 4.14.3 KELUN Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 KELUN Antibiotic API Product Portfolio
  84. 4.14.5 KELUN Recent Developments
  85. 4.15 North China Pharmaceutical
  86. 4.15.1 North China Pharmaceutical Company Information
  87. 4.15.2 North China Pharmaceutical Business Overview
  88. 4.15.3 North China Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 North China Pharmaceutical Antibiotic API Product Portfolio
  90. 4.15.5 North China Pharmaceutical Recent Developments
  91. 4.16 Harbin Pharmaceutical Group
  92. 4.16.1 Harbin Pharmaceutical Group Company Information
  93. 4.16.2 Harbin Pharmaceutical Group Business Overview
  94. 4.16.3 Harbin Pharmaceutical Group Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Harbin Pharmaceutical Group Antibiotic API Product Portfolio
  96. 4.16.5 Harbin Pharmaceutical Group Recent Developments
  97. 4.17 FUKANG PHARMACEUTICAL
  98. 4.17.1 FUKANG PHARMACEUTICAL Company Information
  99. 4.17.2 FUKANG PHARMACEUTICAL Business Overview
  100. 4.17.3 FUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 FUKANG PHARMACEUTICAL Antibiotic API Product Portfolio
  102. 4.17.5 FUKANG PHARMACEUTICAL Recent Developments
  103. 4.18 FUAN PHARMACEUTICAL
  104. 4.18.1 FUAN PHARMACEUTICAL Company Information
  105. 4.18.2 FUAN PHARMACEUTICAL Business Overview
  106. 4.18.3 FUAN PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 FUAN PHARMACEUTICAL Antibiotic API Product Portfolio
  108. 4.18.5 FUAN PHARMACEUTICAL Recent Developments
  109. 4.19 Orchid Pharma
  110. 4.19.1 Orchid Pharma Company Information
  111. 4.19.2 Orchid Pharma Business Overview
  112. 4.19.3 Orchid Pharma Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Orchid Pharma Antibiotic API Product Portfolio
  114. 4.19.5 Orchid Pharma Recent Developments
  115. 4.20 Nectar Lifesciences
  116. 4.20.1 Nectar Lifesciences Company Information
  117. 4.20.2 Nectar Lifesciences Business Overview
  118. 4.20.3 Nectar Lifesciences Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Nectar Lifesciences Antibiotic API Product Portfolio
  120. 4.20.5 Nectar Lifesciences Recent Developments
  121. 4.21 Centrient Pharmaceuticals
  122. 4.21.1 Centrient Pharmaceuticals Company Information
  123. 4.21.2 Centrient Pharmaceuticals Business Overview
  124. 4.21.3 Centrient Pharmaceuticals Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Centrient Pharmaceuticals Antibiotic API Product Portfolio
  126. 4.21.5 Centrient Pharmaceuticals Recent Developments
  127. 4.22 Aurobindo Pharma
  128. 4.22.1 Aurobindo Pharma Company Information
  129. 4.22.2 Aurobindo Pharma Business Overview
  130. 4.22.3 Aurobindo Pharma Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Aurobindo Pharma Antibiotic API Product Portfolio
  132. 4.22.5 Aurobindo Pharma Recent Developments
  133. 4.23 ACS Dobfar
  134. 4.23.1 ACS Dobfar Company Information
  135. 4.23.2 ACS Dobfar Business Overview
  136. 4.23.3 ACS Dobfar Antibiotic API Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 ACS Dobfar Antibiotic API Product Portfolio
  138. 4.23.5 ACS Dobfar Recent Developments
5 Global Antibiotic API Market Scenario by Region
  1. 5.1 Global Antibiotic API Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Antibiotic API Sales by Region: 2021-2032
  3. 5.2.1 Global Antibiotic API Sales by Region: 2021-2026
  4. 5.2.2 Global Antibiotic API Sales by Region: 2027-2032
  5. 5.3 Global Antibiotic API Revenue by Region: 2021-2032
  6. 5.3.1 Global Antibiotic API Revenue by Region: 2021-2026
  7. 5.3.2 Global Antibiotic API Revenue by Region: 2027-2032
  8. 5.4 North America Antibiotic API Market Facts & Figures by Country
  9. 5.4.1 North America Antibiotic API Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Antibiotic API Sales by Country (2021-2032)
  11. 5.4.3 North America Antibiotic API Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Antibiotic API Market Facts & Figures by Country
  15. 5.5.1 Europe Antibiotic API Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Antibiotic API Sales by Country (2021-2032)
  17. 5.5.3 Europe Antibiotic API Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Antibiotic API Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Antibiotic API Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Antibiotic API Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Antibiotic API Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Antibiotic API Market Facts & Figures by Country
  36. 5.7.1 South America Antibiotic API Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Antibiotic API Sales by Country (2021-2032)
  38. 5.7.3 South America Antibiotic API Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.8 Middle East and Africa Antibiotic API Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Antibiotic API Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Antibiotic API Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Antibiotic API Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Antibiotic API Sales by Type (2021-2032)
  2. 6.1.1 Global Antibiotic API Sales by Type (2021-2032) & (Tons)
  3. 6.1.2 Global Antibiotic API Sales Market Share by Type (2021-2032)
  4. 6.2 Global Antibiotic API Revenue by Type (2021-2032)
  5. 6.2.1 Global Antibiotic API Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Antibiotic API Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Antibiotic API Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Antibiotic API Sales by Application (2021-2032)
  2. 7.1.1 Global Antibiotic API Sales by Application (2021-2032) & (Tons)
  3. 7.1.2 Global Antibiotic API Sales Market Share by Application (2021-2032)
  4. 7.2 Global Antibiotic API Revenue by Application (2021-2032)
  5. 7.2.1 Global Antibiotic API Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Antibiotic API Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Antibiotic API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Antibiotic API Value Chain Analysis
  2. 8.1.1 Antibiotic API Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Antibiotic API Production Mode & Process
  5. 8.2 Antibiotic API Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Antibiotic API Distributors
  8. 8.2.3 Antibiotic API Customers
9 Global Antibiotic API Analyzing Market Dynamics
  1. 9.1 Antibiotic API Industry Trends
  2. 9.2 Antibiotic API Industry Drivers
  3. 9.3 Antibiotic API Industry Opportunities and Challenges
  4. 9.4 Antibiotic API Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst